Dermatology Times, December 2022 (Vol. 43. No. 12)

To date, it is unknown what impact potential response-adapted treatment strategies for advanced melanoma may have economically.

Dermatology Times® spoke with Shah in November on how he uses his social media platform to fight healthy skin misinformation.

Dermatology Times®’ Editorial Board offers insight on what they loved about 2022, and what they hope to see in 2023.

Pulsed dye lasers are now being used for several different dermatologic conditions.

Clinicians fresh from the Fall Clinical Dermatology Conference discuss their top meeting takeaways and share some recommendations.

This month's Legal Eagle column explores a scenario of marketing vs. misrepresentation.

Understanding traction alopecia (TA) is essential to helping patients prevent hair loss and repair damage.

A variety of topicals and biologics are now available to treat children affected by this challenging condition.

In this DermView series recap, Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, review the changing landscape of atopic dermatitis treatment options and what is on the horizon.

Patients are finding relief in alternative therapy for the chronic skin disease.

Truncal acne, or back acne, is a common skin condition of the pilosebaceous unit, with a global lifetime prevalence of 70% to 85%.

Choosing an investment adviser can be an extremely important decision for the long-term financial security of any clinician.

In this month's Cosmetic Condundrums columns, Zoe Diana Draelos, MD, discussed growth factors for anti-aging.

Blastic plasmacytoid dendritic neoplasm is commonly misdiagnosed as various forms of leukemia.

At the 2022 SDPA Conference, Ted Rosen, MD, discusses skin conditions that could often be mistaken for vitiligo.

Blastic plasmacytoid dendritis cell neoplasm is a rare and aggressive form of cancer that usually makes its appearance in the form of red to violet papules and plaques.

Erythropoietic protoporphyria (EPP) is a life-long and debilitating disorder resulting from defects in the enzymes in heme synthesis. Patients with the disease are cast indoors due to extreme photosensitivity.